Literature DB >> 12672127

Identification of thiols and glutathione conjugates of depsipeptide FK228 (FR901228), a novel histone protein deacetylase inhibitor, in the blood.

Jim J Xiao1, John Byrd, Guido Marcucci, Michael Grever, Kenneth K Chan.   

Abstract

Four glutathione (GSH) conjugates and two thiols were detected when depsipeptide FK228, formerly FR901228, a naturally occurring potent histone deacetylase (HDAC) inhibitor, was incubated in rat or human plasma in the presence of GSH. Their structures were elucidated by the high-performance liquid chromatography/electrospray ionization multi-stage mass spectrometry (HPLC/ESI-MS(n)) technique, and in some cases confirmed by accurate mass measurement. These products were also detected in rat and human blood homogenates following their incubation with FK228, but were not detected in GSH solution alone. A possible scheme for its formation is proposed. One of the thiols has recently been found to be more active as a histone deacetylase inhibitor than the parent compound. Copyright 2003 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12672127     DOI: 10.1002/rcm.976

Source DB:  PubMed          Journal:  Rapid Commun Mass Spectrom        ISSN: 0951-4198            Impact factor:   2.419


  8 in total

1.  Characterization of a gene cluster responsible for the biosynthesis of anticancer agent FK228 in Chromobacterium violaceum No. 968.

Authors:  Yi-Qiang Cheng; Min Yang; Andrea M Matter
Journal:  Appl Environ Microbiol       Date:  2007-03-30       Impact factor: 4.792

Review 2.  Romidepsin (Istodax, NSC 630176, FR901228, FK228, depsipeptide): a natural product recently approved for cutaneous T-cell lymphoma.

Authors:  Karen M VanderMolen; William McCulloch; Cedric J Pearce; Nicholas H Oberlies
Journal:  J Antibiot (Tokyo)       Date:  2011-05-18       Impact factor: 2.649

3.  Interpreting clinical assays for histone deacetylase inhibitors.

Authors:  Nadine Martinet; Philippe Bertrand
Journal:  Cancer Manag Res       Date:  2011-05-09       Impact factor: 3.989

4.  Differential response of cancer cells to HDAC inhibitors trichostatin A and depsipeptide.

Authors:  J Chang; D S Varghese; M C Gillam; M Peyton; B Modi; R L Schiltz; L Girard; E D Martinez
Journal:  Br J Cancer       Date:  2011-12-08       Impact factor: 7.640

5.  FK228 Analogues Induce Fetal Hemoglobin in Human Erythroid Progenitors.

Authors:  Levi Makala; Salvatore Di Maro; Tzu-Fang Lou; Sharanya Sivanand; Jung-Mo Ahn; Betty S Pace
Journal:  Anemia       Date:  2012-05-14

6.  Chromobacterium spp. mediate their anti-Plasmodium activity through secretion of the histone deacetylase inhibitor romidepsin.

Authors:  Raúl G Saraiva; Callie R Huitt-Roehl; Abhai Tripathi; Yi-Qiang Cheng; Jürgen Bosch; Craig A Townsend; George Dimopoulos
Journal:  Sci Rep       Date:  2018-04-18       Impact factor: 4.379

Review 7.  Epigenetic regulation in human cancer: the potential role of epi-drug in cancer therapy.

Authors:  Yuanjun Lu; Yau-Tuen Chan; Hor-Yue Tan; Sha Li; Ning Wang; Yibin Feng
Journal:  Mol Cancer       Date:  2020-04-27       Impact factor: 27.401

8.  Synthesis and late stage modifications of Cyl derivatives.

Authors:  Phil Servatius; Uli Kazmaier
Journal:  Beilstein J Org Chem       Date:  2022-02-04       Impact factor: 2.883

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.